The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Small Nucleic Acid Drugs for Hepatitis B Market Research Report 2025
Synopsis
The global market for Small Nucleic Acid Drugs for Hepatitis B was valued at US$ 857 million in the year 2024 and is projected to reach a revised size of US$ 1224 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Small Nucleic Acid Drugs for Hepatitis B are targeted anti-HBV therapeutics based on RNA interference or antisense oligonucleotide technology. They inhibit HBV replication by specifically silencing viral gene expression, effectively reducing hepatitis B surface antigen (HBsAg) and other viral protein levels. These drugs hold promise as a key component in achieving functional cure for HBV, with some candidates offering extended dosing intervals of several months. Currently, multiple pharmaceutical companies are advancing clinical trials to evaluate the potential of small nucleic acid drugs as monotherapy or in combination regimens.
North American market for Small Nucleic Acid Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Nucleic Acid Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Nucleic Acid Drugs for Hepatitis B in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Nucleic Acid Drugs for Hepatitis B include Arbutus Biopharma, GSK, Ascletis, Ausperbio, Janssen Biotech (Johnson & Johnson), Brii Biosciences, Barinthus Biotherapeutics, Suzhou Ribo Life Science, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid Drugs for Hepatitis B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid Drugs for Hepatitis B.
The Small Nucleic Acid Drugs for Hepatitis B market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Nucleic Acid Drugs for Hepatitis B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Nucleic Acid Drugs for Hepatitis B companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arbutus Biopharma
GSK
Ascletis
Ausperbio
Janssen Biotech (Johnson & Johnson)
Brii Biosciences
Barinthus Biotherapeutics
Suzhou Ribo Life Science
Segment by Type
Antisense Oligonucleotide (ASO) Drugs
siRNA Drugs
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid Drugs for Hepatitis B company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Small Nucleic Acid Drugs for Hepatitis B was valued at US$ 857 million in the year 2024 and is projected to reach a revised size of US$ 1224 million by 2031, growing at a CAGR of 5.6% during the forecast period.
Small Nucleic Acid Drugs for Hepatitis B are targeted anti-HBV therapeutics based on RNA interference or antisense oligonucleotide technology. They inhibit HBV replication by specifically silencing viral gene expression, effectively reducing hepatitis B surface antigen (HBsAg) and other viral protein levels. These drugs hold promise as a key component in achieving functional cure for HBV, with some candidates offering extended dosing intervals of several months. Currently, multiple pharmaceutical companies are advancing clinical trials to evaluate the potential of small nucleic acid drugs as monotherapy or in combination regimens.
North American market for Small Nucleic Acid Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Nucleic Acid Drugs for Hepatitis B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Nucleic Acid Drugs for Hepatitis B in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Nucleic Acid Drugs for Hepatitis B include Arbutus Biopharma, GSK, Ascletis, Ausperbio, Janssen Biotech (Johnson & Johnson), Brii Biosciences, Barinthus Biotherapeutics, Suzhou Ribo Life Science, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Nucleic Acid Drugs for Hepatitis B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Nucleic Acid Drugs for Hepatitis B.
The Small Nucleic Acid Drugs for Hepatitis B market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Nucleic Acid Drugs for Hepatitis B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Nucleic Acid Drugs for Hepatitis B companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Arbutus Biopharma
GSK
Ascletis
Ausperbio
Janssen Biotech (Johnson & Johnson)
Brii Biosciences
Barinthus Biotherapeutics
Suzhou Ribo Life Science
Segment by Type
Antisense Oligonucleotide (ASO) Drugs
siRNA Drugs
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Nucleic Acid Drugs for Hepatitis B company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antisense Oligonucleotide (ASO) Drugs
1.2.3 siRNA Drugs
1.3 Market by Application
1.3.1 Global Small Nucleic Acid Drugs for Hepatitis B Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Nucleic Acid Drugs for Hepatitis B Market Perspective (2020-2031)
2.2 Global Small Nucleic Acid Drugs for Hepatitis B Growth Trends by Region
2.2.1 Global Small Nucleic Acid Drugs for Hepatitis B Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Nucleic Acid Drugs for Hepatitis B Historic Market Size by Region (2020-2025)
2.2.3 Small Nucleic Acid Drugs for Hepatitis B Forecasted Market Size by Region (2026-2031)
2.3 Small Nucleic Acid Drugs for Hepatitis B Market Dynamics
2.3.1 Small Nucleic Acid Drugs for Hepatitis B Industry Trends
2.3.2 Small Nucleic Acid Drugs for Hepatitis B Market Drivers
2.3.3 Small Nucleic Acid Drugs for Hepatitis B Market Challenges
2.3.4 Small Nucleic Acid Drugs for Hepatitis B Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Nucleic Acid Drugs for Hepatitis B Players by Revenue
3.1.1 Global Top Small Nucleic Acid Drugs for Hepatitis B Players by Revenue (2020-2025)
3.1.2 Global Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share by Players (2020-2025)
3.2 Global Top Small Nucleic Acid Drugs for Hepatitis B Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Nucleic Acid Drugs for Hepatitis B Revenue
3.4 Global Small Nucleic Acid Drugs for Hepatitis B Market Concentration Ratio
3.4.1 Global Small Nucleic Acid Drugs for Hepatitis B Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Nucleic Acid Drugs for Hepatitis B Revenue in 2024
3.5 Global Key Players of Small Nucleic Acid Drugs for Hepatitis B Head office and Area Served
3.6 Global Key Players of Small Nucleic Acid Drugs for Hepatitis B, Product and Application
3.7 Global Key Players of Small Nucleic Acid Drugs for Hepatitis B, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Nucleic Acid Drugs for Hepatitis B Breakdown Data by Type
4.1 Global Small Nucleic Acid Drugs for Hepatitis B Historic Market Size by Type (2020-2025)
4.2 Global Small Nucleic Acid Drugs for Hepatitis B Forecasted Market Size by Type (2026-2031)
5 Small Nucleic Acid Drugs for Hepatitis B Breakdown Data by Application
5.1 Global Small Nucleic Acid Drugs for Hepatitis B Historic Market Size by Application (2020-2025)
5.2 Global Small Nucleic Acid Drugs for Hepatitis B Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Nucleic Acid Drugs for Hepatitis B Market Size (2020-2031)
6.2 North America Small Nucleic Acid Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025)
6.4 North America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Nucleic Acid Drugs for Hepatitis B Market Size (2020-2031)
7.2 Europe Small Nucleic Acid Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025)
7.4 Europe Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size (2020-2031)
8.2 Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size (2020-2031)
9.2 Latin America Small Nucleic Acid Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025)
9.4 Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size (2020-2031)
10.2 Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Arbutus Biopharma
11.1.1 Arbutus Biopharma Company Details
11.1.2 Arbutus Biopharma Business Overview
11.1.3 Arbutus Biopharma Small Nucleic Acid Drugs for Hepatitis B Introduction
11.1.4 Arbutus Biopharma Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.1.5 Arbutus Biopharma Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Small Nucleic Acid Drugs for Hepatitis B Introduction
11.2.4 GSK Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Ascletis
11.3.1 Ascletis Company Details
11.3.2 Ascletis Business Overview
11.3.3 Ascletis Small Nucleic Acid Drugs for Hepatitis B Introduction
11.3.4 Ascletis Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.3.5 Ascletis Recent Development
11.4 Ausperbio
11.4.1 Ausperbio Company Details
11.4.2 Ausperbio Business Overview
11.4.3 Ausperbio Small Nucleic Acid Drugs for Hepatitis B Introduction
11.4.4 Ausperbio Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.4.5 Ausperbio Recent Development
11.5 Janssen Biotech (Johnson & Johnson)
11.5.1 Janssen Biotech (Johnson & Johnson) Company Details
11.5.2 Janssen Biotech (Johnson & Johnson) Business Overview
11.5.3 Janssen Biotech (Johnson & Johnson) Small Nucleic Acid Drugs for Hepatitis B Introduction
11.5.4 Janssen Biotech (Johnson & Johnson) Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.5.5 Janssen Biotech (Johnson & Johnson) Recent Development
11.6 Brii Biosciences
11.6.1 Brii Biosciences Company Details
11.6.2 Brii Biosciences Business Overview
11.6.3 Brii Biosciences Small Nucleic Acid Drugs for Hepatitis B Introduction
11.6.4 Brii Biosciences Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.6.5 Brii Biosciences Recent Development
11.7 Barinthus Biotherapeutics
11.7.1 Barinthus Biotherapeutics Company Details
11.7.2 Barinthus Biotherapeutics Business Overview
11.7.3 Barinthus Biotherapeutics Small Nucleic Acid Drugs for Hepatitis B Introduction
11.7.4 Barinthus Biotherapeutics Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.7.5 Barinthus Biotherapeutics Recent Development
11.8 Suzhou Ribo Life Science
11.8.1 Suzhou Ribo Life Science Company Details
11.8.2 Suzhou Ribo Life Science Business Overview
11.8.3 Suzhou Ribo Life Science Small Nucleic Acid Drugs for Hepatitis B Introduction
11.8.4 Suzhou Ribo Life Science Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
11.8.5 Suzhou Ribo Life Science Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Antisense Oligonucleotide (ASO) Drugs
Table 3. Key Players of siRNA Drugs
Table 4. Global Small Nucleic Acid Drugs for Hepatitis B Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Small Nucleic Acid Drugs for Hepatitis B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Nucleic Acid Drugs for Hepatitis B Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Region (2020-2025)
Table 8. Global Small Nucleic Acid Drugs for Hepatitis B Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Region (2026-2031)
Table 10. Small Nucleic Acid Drugs for Hepatitis B Market Trends
Table 11. Small Nucleic Acid Drugs for Hepatitis B Market Drivers
Table 12. Small Nucleic Acid Drugs for Hepatitis B Market Challenges
Table 13. Small Nucleic Acid Drugs for Hepatitis B Market Restraints
Table 14. Global Small Nucleic Acid Drugs for Hepatitis B Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Players (2020-2025)
Table 16. Global Top Small Nucleic Acid Drugs for Hepatitis B Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Nucleic Acid Drugs for Hepatitis B as of 2024)
Table 17. Ranking of Global Top Small Nucleic Acid Drugs for Hepatitis B Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Small Nucleic Acid Drugs for Hepatitis B Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Small Nucleic Acid Drugs for Hepatitis B, Headquarters and Area Served
Table 20. Global Key Players of Small Nucleic Acid Drugs for Hepatitis B, Product and Application
Table 21. Global Key Players of Small Nucleic Acid Drugs for Hepatitis B, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Nucleic Acid Drugs for Hepatitis B Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share by Type (2020-2025)
Table 25. Global Small Nucleic Acid Drugs for Hepatitis B Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share by Type (2026-2031)
Table 27. Global Small Nucleic Acid Drugs for Hepatitis B Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share by Application (2020-2025)
Table 29. Global Small Nucleic Acid Drugs for Hepatitis B Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Small Nucleic Acid Drugs for Hepatitis B Revenue Market Share by Application (2026-2031)
Table 31. North America Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size by Country (2026-2031) & (US$ Million)
Table 46. Arbutus Biopharma Company Details
Table 47. Arbutus Biopharma Business Overview
Table 48. Arbutus Biopharma Small Nucleic Acid Drugs for Hepatitis B Product
Table 49. Arbutus Biopharma Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 50. Arbutus Biopharma Recent Development
Table 51. GSK Company Details
Table 52. GSK Business Overview
Table 53. GSK Small Nucleic Acid Drugs for Hepatitis B Product
Table 54. GSK Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Ascletis Company Details
Table 57. Ascletis Business Overview
Table 58. Ascletis Small Nucleic Acid Drugs for Hepatitis B Product
Table 59. Ascletis Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 60. Ascletis Recent Development
Table 61. Ausperbio Company Details
Table 62. Ausperbio Business Overview
Table 63. Ausperbio Small Nucleic Acid Drugs for Hepatitis B Product
Table 64. Ausperbio Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 65. Ausperbio Recent Development
Table 66. Janssen Biotech (Johnson & Johnson) Company Details
Table 67. Janssen Biotech (Johnson & Johnson) Business Overview
Table 68. Janssen Biotech (Johnson & Johnson) Small Nucleic Acid Drugs for Hepatitis B Product
Table 69. Janssen Biotech (Johnson & Johnson) Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 70. Janssen Biotech (Johnson & Johnson) Recent Development
Table 71. Brii Biosciences Company Details
Table 72. Brii Biosciences Business Overview
Table 73. Brii Biosciences Small Nucleic Acid Drugs for Hepatitis B Product
Table 74. Brii Biosciences Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 75. Brii Biosciences Recent Development
Table 76. Barinthus Biotherapeutics Company Details
Table 77. Barinthus Biotherapeutics Business Overview
Table 78. Barinthus Biotherapeutics Small Nucleic Acid Drugs for Hepatitis B Product
Table 79. Barinthus Biotherapeutics Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 80. Barinthus Biotherapeutics Recent Development
Table 81. Suzhou Ribo Life Science Company Details
Table 82. Suzhou Ribo Life Science Business Overview
Table 83. Suzhou Ribo Life Science Small Nucleic Acid Drugs for Hepatitis B Product
Table 84. Suzhou Ribo Life Science Revenue in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025) & (US$ Million)
Table 85. Suzhou Ribo Life Science Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
Table 89. Authors List of This Report
List of Figures
Figure 1. Small Nucleic Acid Drugs for Hepatitis B Picture
Figure 2. Global Small Nucleic Acid Drugs for Hepatitis B Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Type: 2024 VS 2031
Figure 4. Antisense Oligonucleotide (ASO) Drugs Features
Figure 5. siRNA Drugs Features
Figure 6. Global Small Nucleic Acid Drugs for Hepatitis B Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Small Nucleic Acid Drugs for Hepatitis B Report Years Considered
Figure 12. Global Small Nucleic Acid Drugs for Hepatitis B Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Small Nucleic Acid Drugs for Hepatitis B Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Region: 2024 VS 2031
Figure 15. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Players in 2024
Figure 16. Global Small Nucleic Acid Drugs for Hepatitis B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Small Nucleic Acid Drugs for Hepatitis B Revenue in 2024
Figure 18. North America Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Small Nucleic Acid Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 20. United States Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Small Nucleic Acid Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 24. Germany Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Small Nucleic Acid Drugs for Hepatitis B Market Share by Region (2020-2031)
Figure 32. China Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Small Nucleic Acid Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 40. Mexico Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Small Nucleic Acid Drugs for Hepatitis B Market Share by Country (2020-2031)
Figure 44. Turkey Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Small Nucleic Acid Drugs for Hepatitis B Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Arbutus Biopharma Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 48. GSK Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 49. Ascletis Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 50. Ausperbio Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 51. Janssen Biotech (Johnson & Johnson) Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 52. Brii Biosciences Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 53. Barinthus Biotherapeutics Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 54. Suzhou Ribo Life Science Revenue Growth Rate in Small Nucleic Acid Drugs for Hepatitis B Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
